GLP-1 receptor agonists cause diarrhea in approximately 2030% of users by accelerating gastric emptying and increasing intestinal fluid secretion
J.GibbonsE.BaileyR
Braunstein CR, Noronha JC, Glenn AJ, Viguiliouk E, Noseworthy R, Khan TA, et al
It depends on whether the additional treatments are effective or of questionable benefit, Abaluck says
The combination of these two mechanisms makes Tirzepatide more potent for both glucose regulation and weight loss compared to other medications that act on GLP-1 alone, such as Semaglutide No
Animal studies have demonstrated its ability to regenerate epithelial layers, improve elasticity, and accelerate collagen deposition